JP Morgan Chase
COCH icon

JP Morgan Chase’s Envoy Medical COCH Stock Holding History

JP Morgan Chase’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19
Closed -$25 – 7158
2025
Q1 		$25 Sell
19
-2
-10% -$3 ﹤0.01% 7086
2024
Q4 		$31 Hold
21
– – ﹤0.01% 7204
2024
Q3 		$68 Hold
21
– – ﹤0.01% 7062
2024
Q2 		$50 Buy
+21
New +$78 ﹤0.01% 7029
2022
Q4 		– Sell
-24,000
Closed -$236K – 6597
2022
Q3 		$236K Sell
24,000
-77,079
-76% -$757K ﹤0.01% 4871
2022
Q2 		$991K Sell
101,079
-46,185
-31% -$452K ﹤0.01% 4085
2022
Q1 		$1.44M Sell
147,264
-249
-0.2% -$2.42K ﹤0.01% 4015
2021
Q4 		$1.44M Buy
147,513
+24,399
+20% +$238K ﹤0.01% 4111
2021
Q3 		$1.19M Buy
123,114
+73,116
+146% +$708K ﹤0.01% 4172
2021
Q2 		$485K Buy
+49,998
New +$486K ﹤0.01% 4717

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return

JP Morgan Chase's COCH Position: Q2 2025 in Review

JP Morgan Chase sold out of Envoy Medical (COCH) in Q2 2025, closing a stake of 19 shares — an estimated $25 sold.

JP Morgan Chase first reported a position in COCH in Q2 2021 and held it in 10 quarters. The position peaked at $1.44M in Q1 2022. 22 funds tracked by Wall St. Rank hold COCH as of Q2 2025.

  • JP Morgan Chase reported no remaining Envoy Medical position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 19 Envoy Medical shares in Q2 2025, an estimated $25.
  • JP Morgan Chase first reported a position in Envoy Medical in Q2 2021 and held it in 10 quarters.
  • JP Morgan Chase's Envoy Medical position peaked at $1.44M in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.